[Ozurdex(®) and aphakia: a combination to avoid].

Abstract

zurdex® (Allergan Inc., Irvine, CA, USA) is a biodegradable mplant for the sustained release of intravitreal dexamethaone which has recently been approved as a treatment for acular edema secondary to retinal venous occlusion and n posterior uveitis of non-infectious cause.1 Ozurdex® has lso demonstrated its efficiency in diabetic and pseudophakic acular… (More)
DOI: 10.1016/j.oftal.2011.11.012

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics